Virus News and Research

Latest Virus News and Research

Researchers warn against relaxing Covid-19 restrictions prematurely

Relaxing Covid-19 restrictions could pave the way for new vaccine-resistant virus mutations – according to researchers at the University of East Anglia and the Earlham Institute.

27 Jul 2021

Off-season resurgence of respiratory viruses poses a threat to vulnerable infants

Canada should anticipate a resurgence of a childhood respiratory virus as COVID-19 physical distancing measures are relaxed, authors warn in CMAJ (Canadian Medical Association Journal).

27 Jul 2021

Higher temperatures could limit the spread of dengue infection

Infection with dengue virus makes mosquitoes more sensitive to warmer temperatures, according to new research led by Penn State researchers.

27 Jul 2021

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

Inhalable nanocatchers that contain hACE2 have been recently developed by a group of researchers, providing a plethora of potential benefits in comparison to existing treatments against COVID-19.

27 Jul 2021

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

A few months ago, the boxy, teal truck parked outside a McDonald's in this Inland Empire city might have drawn hundreds of people willing to stand in line for hours under the scorching sun.

27 Jul 2021

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.

27 Jul 2021

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists from the UK have recently identified an antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine as a potential serum biomarker to diagnose active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server while awaiting peer review.

27 Jul 2021

SARS-CoV-2 interacts with unusual RNA structures in human cells

The study, published in the journal Nucleic Acids Research, demonstrated that G4 ligands, the chemical that binds with G4s, prevent this interaction. The results could pave the way for developing inhibitors of these interactions as potential antiviral compounds.

26 Jul 2021

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

A new study evaluates a commercially available IFN‐γ release assay (IGRA) to determine T-cell responses targeted against SARS-CoV-2.

26 Jul 2021

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

A new study posted to the medRxiv* preprint server derives measures of substantial efficacy for these vaccines in preventing mild to moderate COVID-19 from a group of outpatients with and without a history of vaccination.

26 Jul 2021

SARS-CoV-2 antibodies in breast milk: Study

A new study published on the medRxiv* preprint server explores the presence of immunoglobulin (Ig) antibodies IgA and IgG against SARS-CoV-2 in breast milk secreted by women with confirmed infection. The scientists also delineated the specific antigens targeted by the antibodies.

26 Jul 2021

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.

26 Jul 2021

Insight on strategies for disseminating COVID-19 related practice guidance to dentists

Ruth Lipman, American Dental Association (ADA) Science and Research Institute, Chicago, Ill., U.S., presented the poster "Strategies for Disseminating Guidance to Dentists during the COVID-19 Pandemic" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR).

26 Jul 2021

Rosin soap as a potential SARS-CoV-2 disinfectant

In a research paper recently uploaded to the preprint server bioRxiv* by Bell et al. (July 19th, 2021), the potential of rosin soap as a virucide is investigated, finding a ten-thousand-fold drop in infectivity against enveloped viruses such as influenza and SARS-CoV-2 in particular.

26 Jul 2021

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus.

26 Jul 2021

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.

25 Jul 2021

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

A recent study conducted as a part of the Real-Time Assessment of Community Transmission-2 (REACT-2) program has estimated the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies among adult populations in England.

25 Jul 2021

Virus News and Research

Latest Virus News and Research

Researchers warn against relaxing Covid-19 restrictions prematurely

Off-season resurgence of respiratory viruses poses a threat to vulnerable infants

Higher temperatures could limit the spread of dengue infection

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

Want fries with that vaccine? Even at a fast-food restaurant, pop-up clinics see slow traffic

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

SARS-CoV-2 interacts with unusual RNA structures in human cells

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

SARS-CoV-2 antibodies in breast milk: Study

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Insight on strategies for disseminating COVID-19 related practice guidance to dentists

Rosin soap as a potential SARS-CoV-2 disinfectant

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

CoVizu: Making visual sense of variation in SARS-CoV-2 genomes

CD8+ T cells show gene-dependent variation in cross-reactivity to human coronaviruses

Activation of integrins by SARS-CoV-2 may be key to infection

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in